These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 32987896)

  • 1. The Role of Micro-RNAs and Circulating Tumor Markers as Predictors of Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
    De Palma FDE; Luglio G; Tropeano FP; Pagano G; D'Armiento M; Kroemer G; Maiuri MC; De Palma GD
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and Kinetic Analyses of Circulating Tumor Cells as Predictive Markers of Treatment Response in Locally Advanced Rectal Cancer Patients.
    Troncarelli Flores BC; Souza E Silva V; Ali Abdallah E; Mello CAL; Gobo Silva ML; Gomes Mendes G; Camila Braun A; Aguiar Junior S; Thomé Domingos Chinen L
    Cells; 2019 Jun; 8(7):. PubMed ID: 31247977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor microRNAs Identified by Small RNA Sequencing as Potential Response Predictors in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy.
    Machackova T; Trachtova K; Prochazka V; Grolich T; Farkasova M; Fiala L; Sefr R; Kiss I; Skrovina M; Dosoudil M; Berindan-Neagoe I; Svoboda M; Slaby O; Kala Z
    Cancer Genomics Proteomics; 2020; 17(3):249-257. PubMed ID: 32345666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum hsa-miR-30e As a Potential Biomarker to Predict the Effect of Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer.
    Chen W; Wang W
    Genet Test Mol Biomarkers; 2021 Nov; 25(11):696-706. PubMed ID: 34788143
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular and Dynamic Evaluation of Proteins Related to Resistance to Neoadjuvant Treatment with Chemoradiotherapy in Circulating Tumor Cells of Patients with Locally Advanced Rectal Cancer.
    Silva VSE; Abdallah EA; Flores BCT; Braun AC; Costa DJF; Ruano APC; Gasparini VA; Silva MLG; Mendes GG; Claro LCL; Calsavara VF; Aguiar Junior S; de Mello CAL; Chinen LTD
    Cells; 2021 Jun; 10(6):. PubMed ID: 34207124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ceRNA Networks: The Backbone Role in Neoadjuvant Chemoradiotherapy Resistance/Sensitivity of Locally Advanced Rectal Cancer.
    He L; Chang H; Qi Y; Zhang B; Shao Q
    Technol Cancer Res Treat; 2021; 20():15330338211062313. PubMed ID: 34908512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review of Circulating Tumor DNA as a Biomarker Guide for Total Neoadjuvant Therapy in Patients with Locally Advanced Rectal Cancer.
    Yahya J; Baber M; Nabavizadeh N; Goodyear SM; Kardosh A
    J Gastrointest Cancer; 2023 Dec; 54(4):1140-1150. PubMed ID: 36719559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promises and Challenges of Predictive Blood Biomarkers for Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.
    Machado Carvalho JV; Dutoit V; Corrò C; Koessler T
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.
    Lopes-Ramos CM; Habr-Gama A; Quevedo Bde S; Felício NM; Bettoni F; Koyama FC; Asprino PF; Galante PA; Gama-Rodrigues J; Camargo AA; Perez RO; Parmigiani RB
    BMC Med Genomics; 2014 Dec; 7():68. PubMed ID: 25496125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locally advanced rectal cancer transcriptomic-based secretome analysis reveals novel biomarkers useful to identify patients according to neoadjuvant chemoradiotherapy response.
    Canto LMD; Cury SS; Barros-Filho MC; Kupper BEC; Begnami MDFS; Scapulatempo-Neto C; Carvalho RF; Marchi FA; Olsen DA; Madsen JS; Havelund BM; Aguiar S; Rogatto SR
    Sci Rep; 2019 Jun; 9(1):8702. PubMed ID: 31213644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study.
    Wang Y; Yang L; Bao H; Fan X; Xia F; Wan J; Shen L; Guan Y; Bao H; Wu X; Xu Y; Shao Y; Sun Y; Tong T; Li X; Xu Y; Cai S; Zhu J; Zhang Z
    PLoS Med; 2021 Aug; 18(8):e1003741. PubMed ID: 34464382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer.
    Dayde D; Tanaka I; Jain R; Tai MC; Taguchi A
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profiling of locally-advanced rectal adenocarcinoma using microRNA expression (Review).
    Pettit C; Walston S; Wald P; Webb A; Williams TM
    Int J Oncol; 2017 Aug; 51(2):393-404. PubMed ID: 28627602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GOLPH3 overexpression correlates with poor response to neoadjuvant therapy and prognosis in locally advanced rectal cancer.
    Zhu K; Zhao Q; Yue J; Shi P; Yan H; Xu X; Wang R
    Oncotarget; 2016 Oct; 7(42):68328-68338. PubMed ID: 27634904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal Cancer.
    Dayde D; Gunther J; Hirayama Y; Weksberg DC; Boutin A; Parhy G; Aguilar-Bonavides C; Wang H; Katayama H; Abe Y; Do KA; Hara K; Kinoshita T; Komori K; Shimizu Y; Tajika M; Niwa Y; Wang YA; DePinho R; Hanash S; Krishnan S; Taguchi A
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A good preoperative immune prognostic index is precits a better prognosis for locally advanced rectal cancer patients with ypTNM stage II who underwent radical resection after neoadjuvant chemoradiotherapy.
    Li S; Wang Y; Cai H; Pan Z; Guan G
    Int J Colorectal Dis; 2023 Jul; 38(1):184. PubMed ID: 37395868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer.
    Zhang Y; Yan L; Wu Y; Xu M; Liu X; Guan G
    BMC Cancer; 2020 Sep; 20(1):854. PubMed ID: 32891131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the pathological response to neoadjuvant chemoradiation using untargeted metabolomics in locally advanced rectal cancer.
    Jia H; Shen X; Guan Y; Xu M; Tu J; Mo M; Xie L; Yuan J; Zhang Z; Cai S; Zhu J; Zhu Z
    Radiother Oncol; 2018 Sep; 128(3):548-556. PubMed ID: 30041962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.
    Dudani S; Marginean H; Tang PA; Monzon JG; Raissouni S; Asmis TR; Goodwin RA; Gotfrit J; Cheung WY; Vickers MM
    BMC Cancer; 2019 Jul; 19(1):664. PubMed ID: 31277604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers and Molecular Imaging as Predictors of Response to Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.
    Molinari C; Matteucci F; Caroli P; Passardi A
    Clin Colorectal Cancer; 2015 Dec; 14(4):227-38. PubMed ID: 26170142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.